JONATHAN LIVERS: Open Payments
NPI 1336608793 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$950 in 48 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $176 · 2025 $950
Food & beverage: $950
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $223 |
| GlaxoSmithKline, LLC. | 8 | $175 |
| AstraZeneca Pharmaceuticals LP | 6 | $140 |
| PFIZER INC. | 6 | $108 |
| Lilly USA, LLC | 3 | $58 |
| Phathom Pharmaceuticals, Inc. | 4 | $58 |
| Abbott Laboratories | 2 | $43 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Astellas Pharma US Inc | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
Products named: TRELEGY ELLIPTA, Ozempic, BREZTRI, JARDIANCE, ELIQUIS, AIRSUPRA, VOQUEZNA, Rybelsus.
Industry payments across MD — which companies pay providers there.
